CS Genetics Appoints Jeremy Preston, PhD, as Chief Commercial Officer

Genomics Industry Veteran to Spearhead Commercialization of Disruptive Platform that will Increase Access to Single Cell Samples and Accelerate Market Adoption SAN DIEGO, Calif. and CAMBRIDGE, UK - CS Genetics, a privately held genomics-technology company, today announced the appointment of Jeremy Preston, PhD, as Chief Commercial Officer. Jeremy will lead global sales, marketing, and customer-support activities as [...]

Paradigm4 Joins the Tetra Partner Network to Leverage Tetra Data into High-performing Analytical Computing Applications for Pharmaceutical Customers

Partnership Signals Continued Recognition of Tetra Data as a Universally Adoptable Scientific Data Standard  BOSTON, Mass. -- TetraScience, the R&D Data Cloud company, announced today that Paradigm4, an integrated scientific data analytics company, has joined the Tetra Partner Network (TPN) so that pharmaceutical customers can accelerate research decision-making using Tetra Data as a foundation for analytical [...]

Nanalysis Enters into a Letter of Intent to Acquire Quad Systems AG

CALGARY, Alberta - Nanalysis Scientific Corp. (TSXV:NSCI, OTCQX:NSCIF, FRA:1N1) ("Nanalysis" or the "Company") is pleased to announce that it has entered into a letter of intent to acquire QUAD Systems AG (Quad Systems), a Zurich-based Nuclear Magnetic Resonance (NMR) company focused on high-field NMR for pharmaceutical and other vertical markets. Quad Systems and Nanalysis have been working together [...]

M2GEN Expands Leadership Team, Appointing Daniel Elgort, Ph.D. as Chief Data and Analytics Officer and May Yoon as Chief People Officer

Accelerates company’s long-term growth strategy and the evolution of its industry-leading clinico-genomic data capabilities TAMPA, FL -- M2GEN, a bioinformatics company accelerating discoveries in oncology research through industry leading data and analytics, today announced that it has expanded its executive team with the appointments of Daniel Elgort, Ph.D., as Chief Data and Analytics Officer and May Yoon as [...]

Eppendorf & Science Prize for Neurobiology 2022 Call for Entries!

Hamburg -- Eppendorf and the journal Science are now accepting applications for the 2022 Eppendorf & Science Prize for Neurobiology. This annual international research prize of US$25,000 is awarded to young scientists for their outstanding contributions to neurobiological research based on methods of molecular and cell biology. Researchers who are not older than 35 years [...]

CORDENPHARMA COLLABORATES ON CONTINUOUS PEPTIDE MANUFACTURING & GREEN CHEMISTRY

18 January 2022 – Luxembourg > Due to the promising, yet underutilized potential of Green Chemistry and continuous manufacturing synthesis approaches gaining traction in the wider pharmaceutical community, CordenPharma is pleased to announce a collaboration with PeptiSystems, a Swedish-based developer of instruments for peptide and oligonucleotide therapeutic process development and manufacturing based on flow through [...]

BIO-TECHNE ANNOUNCES COMMERCIAL RELEASE OF HIGH SENSITIVITY FLUORESCENT DETECTION STELLAR NIR / IR™ MODULES FOR JESS AUTOMATED WESTERN BLOTTING SYSTEM

Stellar modules set a new standard for western blotting fluorescence detection sensitivity MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH) today announced that ProteinSimple, a Bio-Techne brand, released its Stellar NIR / IR™ Detection Modules for Jess.  Stellar fluorescence modules enable detection of low abundance proteins while multiplexing multiple analytes within the same detection lane, setting a [...]

INDIGO Biosciences Releases New Luciferase Detection Reagent

STATE COLLEGE, Pa. -- INDIGO Biosciences, Inc. (INDIGO), a recognized industry leader in cell-based luciferase reporter assay kits and service, has developed a new luciferase detection reagent and will be offering this new reagent solely for purchase. INDIGlo, the companies new Luciferase Detection Reagent Kit will provide researchers with the ability to purchase the easy-to-use reagent found [...]

PreOmics Announces Closing of Series B Financing to Accelerate Research, Development and Commercialization of Proteomics Tools and Consumables

PreOmics Offers Unique Technologies, Advanced Automation Solutions and High-Performance Consumables for the Homogenization, Enrichment and Sample Preparation of Biopsy, Tissue, Cell Line and Plasma Samples in Unbiased, Deep Proteomics for Biopharma and Clinical Research MUNICH, Germany –  PreOmics GmbH, a Martinsried, Germany-based developer of innovative automation and sample preparation tools and consumables for unbiased, deep [...]

Nuclera announces expansion with new US subsidiary

CAMBRIDGE, UK – Nuclera, a Cambridge, UK-based biotech company developing cutting-edge benchtop protein printing technologies, announces the opening of its US subsidiary located in Boston, MA. The addition of this new US facility in the rapidly growing biotechnology hub of greater Boston USA is a critical step in the company’s plans and will pave the way [...]

Access IBO on Knowledge Center